Susquehanna International Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$383K Buy
11,900
+300
+3% +$11.1K ﹤0.01% 10319
2025
Q4
$488K Buy
11,600
+4,900
+73% +$198K ﹤0.01% 8841
2025
Q3
$230K Sell
6,700
-10,900
-62% -$313K ﹤0.01% 10683
2025
Q2
$476K Buy
17,600
+3,200
+22% +$92.7K ﹤0.01% 9289
2025
Q1
$427K Sell
14,400
-3,500
-20% -$133K ﹤0.01% 9251
2024
Q4
$709K Buy
17,900
+5,300
+42% +$201K ﹤0.01% 7796
2024
Q3
$429K Sell
12,600
-2,200
-15% -$61.9K ﹤0.01% 8846
2024
Q2
$321K Sell
14,800
-36,500
-71% -$767K ﹤0.01% 9301
2024
Q1
$1.14M Buy
51,300
+38,300
+295% +$934K ﹤0.01% 6587
2023
Q4
$358K Sell
13,000
-43,000
-77% -$1.04M ﹤0.01% 9450
2023
Q3
$1.25M Buy
+56,000
New +$1.44M ﹤0.01% 6123
2022
Q3
Sell
-14,000
Closed -$279K 14182
2022
Q2
$279K Sell
14,000
-800
-5% -$16.2K ﹤0.01% 9764
2022
Q1
$408K Sell
14,800
-6,100
-29% -$174K ﹤0.01% 9494
2021
Q4
$861K Buy
20,900
+11,200
+115% +$495K ﹤0.01% 7688
2021
Q3
$451K Sell
9,700
-7,800
-45% -$340K ﹤0.01% 9652
2021
Q2
$700K Buy
17,500
+5,200
+42% +$222K ﹤0.01% 8738
2021
Q1
$661K Sell
12,300
-8,700
-41% -$501K ﹤0.01% 8812
2020
Q4
$1.03M Buy
+21,000
New +$973K ﹤0.01% 6668
2020
Q3
Sell
-19,300
Closed -$500K 11201
2020
Q2
$500K Sell
19,300
-10,200
-35% -$254K ﹤0.01% 7358
2020
Q1
$717K Buy
29,500
+16,300
+123% +$410K ﹤0.01% 6136
2019
Q4
$369K Sell
13,200
-19,500
-60% -$505K ﹤0.01% 7592
2019
Q3
$785K Buy
32,700
+8,500
+35% +$226K ﹤0.01% 6237
2019
Q2
$690K Sell
24,200
-33,600
-58% -$839K ﹤0.01% 6545
2019
Q1
$1.45M Buy
+57,800
New +$1.1M ﹤0.01% 4296
2018
Q2
Sell
-34,200
Closed -$190K 10486
2018
Q1
$190K Sell
34,200
-29,800
-47% -$184K ﹤0.01% 8354
2017
Q4
$418K Sell
64,000
-16,600
-21% -$123K ﹤0.01% 6967
2017
Q3
$707K Buy
80,600
+9,900
+14% +$80.5K ﹤0.01% 5920
2017
Q2
$589K Buy
70,700
+42,900
+154% +$350K ﹤0.01% 6334
2017
Q1
$255K Sell
27,800
-19,000
-41% -$155K ﹤0.01% 7636
2016
Q4
$362K Sell
46,800
-4,200
-8% -$31.4K ﹤0.01% 7612
2016
Q3
$388K Sell
51,000
-62,500
-55% -$353K ﹤0.01% 6517
2016
Q2
$571K Buy
113,500
+20,600
+22% +$110K ﹤0.01% 5899
2016
Q1
$502K Buy
+92,900
New +$549K ﹤0.01% 6393

Other funds holding VCYT

Susquehanna International Group's VCYT Position: Q1 2026 in Review

Susquehanna International Group increased its Veracyte (VCYT) stake by 218% in Q1 2026, buying an estimated $1.91M and bringing the position to 75,258 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #5728.

Susquehanna International Group first reported a position in VCYT in Q1 2016 and has held it in 37 quarters since. The position peaked at $16.5M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Susquehanna International Group held 75,258 shares of Veracyte worth $2.42M as of Q1 2026.
  • Susquehanna International Group bought 51,590 Veracyte shares in Q1 2026, an estimated $1.91M.
  • Veracyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5728 holding.
  • Susquehanna International Group first reported a position in Veracyte in Q1 2016 and has held it in 37 quarters since.
  • Susquehanna International Group's Veracyte position peaked at $16.5M in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.